BioEleSonic – executive interview

Published on 19 April 2022

In this interview, Konstantinos Efthymiopoulos (chairman and managing director of BioEleSonic, a portfolio company of ESGTI) explains what he considers the key growth drivers in the life sciences sector today. He also sheds some light on the major growth constraints and risks, as well as the most impactful regulations and government initiatives in this industry. To conclude, Konstantinos talks us through the key ‘green’ technologies developed by BioEleSonic and summarises the important role of ESG within the sector.

Share this with friends and colleagues